Related Experiment Video

Updated: Jan 4, 2026

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.2K

Left ventricular assist device for pediatric postcardiotomy cardiac failure

De-ming Zhu1, Wei Wang, Hong Chen

  • 1Department of Pediatric Thoracic and Cardiovascular Surgery, Shanghai Children's Medical Center, Shanghai Jiao Tong University, School of Medicine, Shanghai, People's Republic of China.

ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|September 13, 2006
PubMed

Insights

Pediatric patients with severe postcardiotomy heart failure can benefit from centrifugal pump left ventricular assist devices. These mechanical circulatory support devices offer a vital bridge to recovery for critically ill children.

Area of Science:

  • Pediatric Cardiology
  • Mechanical Circulatory Support
  • Cardiac Surgery

Background:

  • Post-cardiotomy heart failure in children presents a critical challenge with limited therapeutic options.
  • Maximal medical management is often insufficient for children with severe postcardiotomy heart failure.
  • Mechanical circulatory support (MCS) is increasingly utilized as a bridge to recovery.

Observation:

  • This study reports on the application of left ventricular assist devices (LVADs) with centrifugal pumps.
  • The devices were used in five pediatric patients weighing less than 15 kg.
  • These patients suffered from postcardiotomy heart failure.

Findings:

  • Left ventricular assist devices (LVADs) utilizing centrifugal pumps were successfully employed in pediatric cases.
  • The LVADs provided short-term mechanical circulatory support for children with postcardiotomy heart failure.
  • This intervention served as a bridge to recovery for the studied pediatric cohort.

Implications:

  • Centrifugal pump LVADs represent a viable therapeutic option for critically ill pediatric patients with postcardiotomy heart failure.
  • Short-term MCS can significantly improve survival outcomes in this vulnerable population.
  • Further research into MCS for pediatric heart failure is warranted to optimize patient selection and device management.

More Related Videos

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

4.0K
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

3.6K

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
287
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
412